Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — November 2021

Zealand Pharma — November 2021

Planlagt Fastgjort Låst Flyttet Zealand Pharma
116 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #107

    Xeris Biopharma q3 2021: "Gvoke: Third quarter 2021 prescriptions topped 27,000 for the first time, growing more than 28% from the prior quarter and 95% compared to the same period in 2020. Gvoke’s NRx share of the retail glucagon market grew to approximately 18% during the third quarter. Gvoke YTD revenue more than doubled to $27.9 million when compared to the same nine-month period in 2020."

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #108

      Salget af Gvoke er ved at komme op i fart, monstro at Zegalogue også finder sin plads i det voksende nødpen-marked.

      1 Reply Last reply
      0
      • T Offline
        T Offline
        TopPhama
        wrote on sidst redigeret af
        #109

        hej exitnu kan det ikke passe at Zealand Parma har en Priority Review Voucher?

        1 Reply Last reply
        0
        • T Offline
          T Offline
          TopPhama
          wrote on sidst redigeret af
          #110

          F
          ra analysen Q3: FDA har tildelt orphan drug designation, hvilket giver skattefordele, kan give en længere årrække med eksklusivitet
          efter en produktgodkendelse, udstedelse af en Priority Review Voucher, statslige tilskud m.m. Der er virkelig behov for nyskabelse til
          gavn for de berørte patienter, og glepaglutide kan blive en game-changer

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #111

            Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021

            Link Preview Image
            Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021

            Company announcement – No. 71 / 2021 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2021 Copenhagen, DK and Boston, MA, November...

            favicon

            GlobeNewswire News Room (www.globenewswire.com)

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #112

              "Following the acquisition of shares in Zealand, Credit Suisse Group AG controls more than 5% of the total voting rights in Zealand and Credit Suisse Group AG holds more than 5% of the total share capital of Zealand."

              1 Reply Last reply
              0
              • SvingtraderenS Offline
                SvingtraderenS Offline
                Svingtraderen
                wrote on sidst redigeret af
                #113

                Du er hurtig - tak

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #114

                  @TopPhama - Orphan Drug Designation

                  "Glepaglutide is a long-acting GLP-2 analog in development for the treatment of SBS. It was granted orphan drug designation by the U.S. FDA and is currently being studied in Phase 3 clinical trials"

                  Blocked

                  Short description

                  favicon

                  (www.zealandpharma.com)

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #115

                    @Svingtraderen - tak selv 🙂

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #116

                      Credit Suisse som storaktionær? Ja, hvorfor ikke. Hvis de kan spotte et potentiale og en pris, der danner base for en investering, er de velkommen i familien.

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #117

                        Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021

                        1 Reply Last reply
                        0

                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                        With your input, this post could be even better 💗

                        Tilmeld Log ind
                        Svar
                        • Svar som emne
                        Login for at svare
                        • Ældste til nyeste
                        • Nyeste til ældste
                        • Most Votes


                        • Log ind

                        • Har du ikke en konto? Tilmeld

                        • Login or register to search.
                        Powered by NodeBB Contributors
                        • First post
                          Last post
                        0
                        • Kategorier
                        • Seneste
                        • Etiketter
                        • Populære
                        • Verden
                        • Bruger
                        • Grupper